CDT Equity Inc.

CDT Healthcare Biotechnology

In the quarter to June 2026, EPS grew 98.0% and free cash flow grew 78.9%, each against the same quarter a year earlier.

0.24 0.03 +14.29%
Market cap
$240.0K
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

839.05% 561.83% (71.01%) (69.68%)
ROA
(351.75%) (796.99%) (57.17%) (55.16%)
ROIC
(2,715.06%) 0.00% (21.83%) (21.28%)
Return on Tangible Assets
(643.79%) 479.98% 209.75% 183.40%
Free Cash Flow per Share
(151,300.00) (159,600.00) (4,662.07) (539.15)
Free Cash Flow
(15.13) (15.96) (13.52) (11.48)
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Oct 2026